Regulation of Gene and Cell Therapy Manufacturing - FDLI



June 8 - June 9, 2021

Global | Virtual |

This conference will explore the latest pre-and post-market regulatory, legal, and compliance issues facing the cell and gene therapy industry.

Conference Highlights:

  • Keynote: Dr. Peter Marks, Director, Center for Biologics Evaluation and Research;
  • Featured Speaker: Dr. Bruce Levine, Barbara and Edward Netter Professor in Cancer Gene Therapy, University of Pennsylvania;
  • Real-life examples from industry experts;
  • The latest on FDA policy, initiatives, and compliance, directly from FDA;
  • Pre-and post-market obstacles and solutions.

Don't miss the Parexel presenation:

Mo Heidaran, VP Technical speaking on "Manufacturing Challenges for  Commercialization of Innovative Cell, and Gene therapy Products"


We are always available for a conversation.


We are always available for a conversation.


Communication Preference

Communication Preference